LILLY 4165 (Evista 60 mg)
Generic Name: raloxifene
Pill imprint LILLY 4165 has been identified as Evista 60 mg.
Evista is used in the treatment of prevention of osteoporosis; breast cancer, prevention; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Evista 60 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 60 mg
- 12.00 mm
- Elliptical / Oval
- Prescription only
Selective estrogen receptor modulators
|NDC Code||Manufacturer / Repackager|
|54569-4628||A-S Medication Solutions, LLC (repackager)|
|54868-4170||Physicians Total Care Inc (repackager)|
|57866-0002||Direct Dispensing Inc (repackager)|
|55289-0266||PDRX Pharmaceuticals Inc (repackager)|
|49999-0458||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Evista (raloxifene)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.